Financial Toxicity and Quality of Life in Patients With TGCT

  • End date
    Dec 21, 2025
  • participants needed
  • sponsor
    The University of Texas Health Science Center at San Antonio
Updated on 21 April 2022


This is a cross-sectional, observational study employing validated questionnaires to investigate financial toxicity in subjects with testicular germ cell tumors (TGCT). As background, TGCTs are the most common malignancies among men from age 15-35. Treatment is highly curative, but often consists of intensive multi-cycle chemotherapy with significant potential for physical toxicity. The treatment course itself is disruptive and long term physical and mental health consequences can increase risk for financial toxicity. Thus, we aim to study financial toxicity in both patients with TGCT actively receiving treatment and in TGCT survivors. There will be two separate cohorts: Cohort 1 will consist of subjects with recently diagnosed TGCT who will undergo multi-agent, multi-cycle chemotherapy and Cohort 2 will consist of subjects who have completed chemotherapy and are long-term survivors.

Condition Testicular Neoplasm
Treatment Comprehensive Score for financial toxicity (COST), Functional Assessment of Cancer Therapy: General (FACT-G), EORTC QLQ C-30, EORTC QLQ-TC26.
Clinical Study IdentifierNCT04531709
SponsorThe University of Texas Health Science Center at San Antonio
Last Modified on21 April 2022


Yes No Not Sure

Inclusion Criteria

Recently diagnosed TGCT
Patients with histologically or clinically confirmed germ cell tumor
Age > 18 years of age
Anticipated treatment with multicycle (> 2 cycles) / multiagent chemotherapy
Within 4 weeks of starting C1D1 chemotherapy
Signed informed consent
Long-term survivors
Age > 18 years of age
Patients with histologically or clinically confirmed germ cell tumor
Completed treatment for germ cell tumor with multicycle (> 2 cycles) / multiagent chemotherapy
Within years 1-5 of surveillance since Day 1 of last cycle of chemotherapy
Signed informed consent

Exclusion Criteria

Recently diagnosed TGCT
Patients planned to receive <2 cycles of chemotherapy
Starting chemotherapy greater than 4 weeks after signing consent and completing initial survey
Starting chemotherapy prior to consenting and completing initial survey
Long-term survivors
Patients undergoing active chemotherapy
Patients who did not complete 1st line chemotherapy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note